Volume 75, Issue 3, Pages (February 2009)

Slides:



Advertisements
Similar presentations
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury  Marisa D. Covington,
Advertisements

Volume 84, Issue 1, Pages (July 2013)
Volume 78, Issue 3, Pages (August 2010)
Volume 78, Issue 11, Pages (December 2010)
Volume 85, Issue 3, Pages (March 2014)
Volume 79, Issue 1, Pages (January 2011)
Volume 81, Issue 8, Pages (April 2012)
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 76, Issue 7, Pages (October 2009)
Volume 88, Issue 3, Pages (September 2015)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 86, Issue 1, Pages (July 2014)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Renal denervation prevents long-term sequelae of ischemic renal injury
Volume 85, Issue 1, Pages (January 2014)
Volume 65, Issue 2, Pages (February 2004)
Volume 82, Issue 8, Pages (October 2012)
The cell cycle and acute kidney injury
Volume 64, Issue 5, Pages (November 2003)
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury  Marisa D. Covington,
Volume 82, Issue 10, Pages (November 2012)
Genistein protects the kidney from cisplatin-induced injury
Volume 75, Issue 2, Pages (January 2009)
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 79, Issue 1, Pages (January 2011)
Volume 70, Issue 2, Pages (July 2006)
Volume 86, Issue 3, Pages (September 2014)
Volume 73, Issue 4, Pages (February 2008)
Volume 82, Issue 9, Pages (November 2012)
Autophagy in proximal tubules protects against acute kidney injury
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 69, Issue 12, Pages (June 2006)
Volume 81, Issue 4, Pages (February 2012)
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 79, Issue 1, Pages (January 2011)
M. Svensson, H. Irjala, C. Svanborg, G. Godaly  Kidney International 
Role of meprin A in renal tubular epithelial cell injury
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 64, Issue 5, Pages (November 2003)
Volume 75, Issue 8, Pages (April 2009)
Volume 80, Issue 12, Pages (December 2011)
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 83, Issue 3, Pages (March 2013)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 73, Issue 12, Pages (June 2008)
Volume 92, Issue 3, Pages (September 2017)
Volume 73, Issue 11, Pages (June 2008)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 60, Issue 6, Pages (December 2001)
Volume 68, Issue 2, Pages (August 2005)
Volume 85, Issue 4, Pages (April 2014)
Volume 85, Issue 4, Pages (April 2014)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 76, Issue 7, Pages (October 2009)
Volume 75, Issue 5, Pages (March 2009)
Volume 83, Issue 6, Pages (June 2013)
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 74, Issue 5, Pages (September 2008)
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 88, Issue 4, Pages (October 2015)
Volume 63, Issue 1, Pages (January 2003)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 67, Issue 4, Pages (April 2005)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 77, Issue 11, Pages (June 2010)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 60, Issue 6, Pages (December 2001)
Volume 75, Issue 8, Pages (April 2009)
Presentation transcript:

Volume 75, Issue 3, Pages 304-311 (February 2009) Suramin promotes recovery from renal ischemia/reperfusion injury in mice  Shougang Zhuang, Bo Lu, Rebecca A. Daubert, Kenneth D. Chavin, Liquan Wang, Rick G. Schnellmann  Kidney International  Volume 75, Issue 3, Pages 304-311 (February 2009) DOI: 10.1038/ki.2008.506 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Effect of delayed administration of suramin on creatinine and BUN in mice subjected to I/R. (a, b) Mice were subjected to 26 min of bilateral renal ischemia and then allowed to recover for 24 or 48 h. (c, d) Five groups of mice were subjected to suramin (Sur) treatment at 24 h after release of renal clamps at the indicated doses. Serum creatinine and BUN levels were measured. Data are shown as means±s.d. Bars with different letters are significantly different from each other (P<0.05). Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Effect of delayed administration of suramin on renal histology (hematoxylin and eosin). Mice were subjected to 26 min of bilateral renal ischemia, and then allowed to recover for 48 h. Suramin (Sur, 1 mg/kg) or vehicle (saline) was given 24 h after release of renal clamps. (a) Sham; (b) I/R+saline; (c) I/R+suramin; (d) tabulated data from scoring of renal tissue damage. Data are shown as means±s.d. Bars with different superscript letters are significantly different from each other (P<0.05). Original magnification= × 100. Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Effect of delayed administration of suramin on apoptosis. Mice were subjected to I/R and treated with suramin (Sur) as described in Figure 2. Representative photographs of the distribution of TUNEL-positive nuclei in kidney of (a) sham, (b) I/R+saline, and (c) suramin+I/R-treated mice are shown. (d) Tabulated data from tissue scoring. Data are shown as means±s.d. Bars with different superscript letters are significantly different from each other (P<0.05). Original magnification= × 200. Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 4 Effect of delayed administration of suramin on caspase-3 activation. Mice were subjected to I/R and treated with suramin (Sur) as described in Figure 2. Anticleaved caspase-3 antibody was used to stain the cells with cleaved caspase-3 in kidney tissue section. (a) sham; (b) I/R+saline; (c) I/R+suramin; (d) tabulated data for numbers of tubular cells with cleaved caspase-3-positive staining. Data are shown as means±s.d. Bars with different superscript letters are significantly different from each other (P<0.05). Original magnification= × 200. Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 5 Effect of delayed administration of suramin on leukocyte infiltration. Mice were subjected to I/R and treated with suramin (Sur) as described in Figure 2. Naphthol AS-D chloroacetate esterase kit was used to stain neutrophils and monocytes in kidney sections of corticomedullary and medullary areas of (a) sham-operated, (b) untreated, and (c) suramin-treated mice, respectively. Infiltration of those cells, seen as deep-purple dots, is more prominent in the injured kidney without suramin treatment. Original magnification= × 200. Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 6 Effect of delayed administration of suramin on tubular cell proliferation. Mice were subjected to I/R and treated with suramin as described in Figure 2. Kidney sections were stained with antibodies to (a) PCNA or (b) phospho-histone H3 (Ser 10). Tabulated data for numbers of tubular cells with (c) positive PCNA or (d) phospho-histone H3 staining. Data are shown as means±s.d. Bars with different letters are significantly different from each other (P<0.05). Original magnification= × 200. Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 7 Effect of P2 antagonists on proliferation of RPTC. RPTC were cultured for 2 days and then incubated with suramin (50 μM), RB2 (100 μM), PPADS (30 μM), or MRS2179 (10 μM) for 48 h. Cell proliferation was determined by measuring the number of cells in S-phase of the cell cycle. Data are expressed as means±s.e.m. (n=3). Bars with different superscripts are significantly different from each other (P<0.05). Kidney International 2009 75, 304-311DOI: (10.1038/ki.2008.506) Copyright © 2009 International Society of Nephrology Terms and Conditions